Thursday, July 19, 2018
 
 
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
The CEO of NeoDocto, USA, Mr. Madhukar Sanneerappa Met Dr. Umesh Phansu Joint Director-Cum-State Programme Officer at Assam, India.

(April 16, 2018)


"The CEO and Global President of NeoDocto Mr. Madhukar Sanneerappa meeting Dr. Umesh Phansu, the Joint Director-Cum-State Programme Office at Assam, India during Neodocto Malaria Eradication Program."
The CEO of NeoDocto Mr. Madhukar Sanneerappa is traveling in Assam to promote the NeoDocto Malaria Eradication Program. In this process, he met the Dr. Umesh Phansu, the joint Director-Cum-State Programme Office at Assam.

Manhattan, New York - April 16, 2018 - Mr. Madhukar Sanneerappa, the CEO and the Global President of NeoDocto is a leader in healthcare technology. He is a leader in long-term vision as well. He is passionate, energetic, honest and a man among men. He wishes to do his best every day to help the world. Charity is his very core and besides being a philanthropist, he is a compassionate leader with dedication and determination to excel and help others. He would truly make a difference in the healthcare domain in the entire world.

As a part of promoting the malaria eradication program, Mr. Madhukar met Dr. Umesh Phansu, Joint Director-cum-state Programme Officer at the office of DHS in Saikia Commercial Complex, Assam Christian Basti at Guwahati. Dr. Umesh is the state representative for the National Vector Borne Disease Control Programme of the Directorate General of Health Services of the Ministry of Health & Family Welfare of Government of India. Dr. Madhukar talked about the Malaria Eradication Program of NeoDocto that is aimed at preventing deaths caused by Malaria by completely eradicating this deadly disease.

The state of Assam along with the Northeast contributes to nearly 10-12% of the total Malaria cases in India. As per the National Framework for Malaria Elimination in India, the state is in the category 2 position with an Annual Parasite Incidence or API of less than a case per 1000 people at risk. Nevertheless, Assam is not out of risk. The reason is that some districts in the state are still considered high endemic districts with an Annual Parasite Incidence of greater than 1.

At the meeting between the CEO of NeoDocto and the Joint Director-cum-state Programme Officer, the former explained about the Malaria Eradication program, which is one of the important core functions of NeoDocto. He explained about the different methods that they will follow to eradicate malaria from the state to help people lead a healthy life.

About NeoDocto Foundation:

NeoDocto Foundation provides excellent support to the society by offering a helping hand for creating equal opportunities and for building a healthy world. The foundation strongly believes that doing good things to the society is their true wealth. With an objective of building a healthy world, they create equal opportunities not just to their partners, but also to their customers. The Corporate Social Responsibility of this foundation is to make efforts to bring down the impact of malaria and for this, they have developed the NeoDocto Malaria Initiative Program.

For more information, please visit https://neodocto.com/

Media Contact

Company Name: NeoDocto Inc.Contact Person: Shanon


Email: [email protected]
Phone: +1(646)583 1581
Address:245 Park Avenue, 39th Floor
City: Manhattan
State: New York, 10167
Country: United States
Website: www.neodocto.com



Source: www.abnewswire.com


Page: 1


Related Keywords:Health & Medicine,India,Science,Technology,U.S,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research
  • Wireless Health Market To Witness Enhanced Growth Owing To Rising Application of Wireless Health Devices And Growing Patient-Centric Methodology Till 2025 | Million Insights
  • Robotics Prosthetics Market Exclusive Analysis by MRFR | Industry Growing with 9.5% CAGR up to 2027 | The Demand for Robotic Prosthetic is Found to be Increasing across the Globe
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR

    Cancer
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  • Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines